|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0035020,
umls-concept:C0138741,
umls-concept:C0180683,
umls-concept:C0185117,
umls-concept:C0332281,
umls-concept:C0376358,
umls-concept:C0546816,
umls-concept:C0599295,
umls-concept:C1336641,
umls-concept:C1515985,
umls-concept:C1533585,
umls-concept:C1548161,
umls-concept:C1551083,
umls-concept:C2911684
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-11-6
|
|
pubmed:abstractText |
The recently identified TMPRSS2: ERG fusion gene is a candidate oncogene for prostate cancer (PCa).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1720-8386
|
|
pubmed:author |
pubmed-author:BaldiEE,
pubmed-author:BonaccorsoJJ,
pubmed-author:CariniMM,
pubmed-author:FangYY,
pubmed-author:FortiGG,
pubmed-author:JhanwarS CSC,
pubmed-author:KrauszCC,
pubmed-author:LaneA EAE,
pubmed-author:LuzzattoLL,
pubmed-author:MasieriLL,
pubmed-author:NutiFF,
pubmed-author:OrlandoCC,
pubmed-author:PaglieraniMM,
pubmed-author:Proietti-PannunziLL,
pubmed-author:Seri?VV
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
590-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19494719-Ablation Techniques,
pubmed-meshheading:19494719-Aged,
pubmed-meshheading:19494719-Androgen Antagonists,
pubmed-meshheading:19494719-Animals,
pubmed-meshheading:19494719-Gene Fusion,
pubmed-meshheading:19494719-Humans,
pubmed-meshheading:19494719-Kaplan-Meier Estimate,
pubmed-meshheading:19494719-Male,
pubmed-meshheading:19494719-Middle Aged,
pubmed-meshheading:19494719-Oncogene Proteins, Fusion,
pubmed-meshheading:19494719-Prostate-Specific Antigen,
pubmed-meshheading:19494719-Prostatectomy,
pubmed-meshheading:19494719-Prostatic Neoplasms,
pubmed-meshheading:19494719-Recurrence,
pubmed-meshheading:19494719-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Persistence of expression of the TMPRSS2:ERG fusion gene after pre-surgery androgen ablation may be associated with early prostate specific antigen relapse of prostate cancer: preliminary results.
|
|
pubmed:affiliation |
Unit of Andrology, Department of Clinical Physiopathology, University of Florence, Florence, Italy. l.bonaccorsi@dfc.unifi.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
